Characterization of the bispecific VHH antibody gefurulimab (ALXN1720) targeting complement component 5, and designed for low volume subcutaneous administration
Titel:
Characterization of the bispecific VHH antibody gefurulimab (ALXN1720) targeting complement component 5, and designed for low volume subcutaneous administration
Auteur:
Jindal, Siddharth Pedersen, Dennis Vestergaard Gera, Nimish Chandler, Julian Patel, Rekha Neill, Alyssa Cone, Josh Zhang, Yuchun Yuan, Chao-Xing Millman, Ellen E. Carlin, Dan Puffer, Bridget Sheridan, Douglas Andersen, Gregers Rom Tamburini, Paul